Literature DB >> 11312569

Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease.

M Rodríguez1, P Barroso-Chinea, P Abdala, J Obeso, T González-Hernández.   

Abstract

In an attempt to find a convenient rat model to study cell vulnerability in Parkinson's disease, we have investigated the cell-loss profile in different midbrain dopaminergic nuclei and subnuclei of rats injected with 6-hydroxydopamine (6-OHDA) in the third ventricle. Following administration of different doses (5-1000 microgram) of 6-OHDA, motor behavior was evaluated and tyrosine hydroxylase-immunostained neurons were counted in the A8 group and different subdivisions of A9 and A10 groups. Animals developed hypokinesia, repetitive chewing movements, and catalepsia. Signs of cell degeneration were evident from the first day after injection, reaching the definitive pattern at the end of the first week. There was a similar degeneration in both brain sides, the A9 group showing the highest degree of cell-loss, followed by A8 and A10 groups. In the A9 group, the degeneration mostly affected those subgroups located in its ventral, lateral, and posterior regions. In the A10 group the degeneration mainly affected the parabrachial pigmented nucleus, the paranigral nucleus and the ventral tegmental area. This topographic pattern of degeneration is very similar to that previously described in Parkinson's disease, suggesting that this model may be a useful tool in the study of the cell vulnerability mechanisms in this neurodegenerative disorder. In addition, our results also showed that small dopaminergic neurons are more resistant to degeneration than the large ones. In some DA subgroups, the cells that contained calbindin but not calretinin were less vulnerable to the neurotoxic effect of 6-OHDA. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312569     DOI: 10.1006/exnr.2000.7624

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  31 in total

1.  An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.

Authors:  Chee Yeun Chung; James B Koprich; Shogo Endo; Ole Isacson
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

2.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

3.  Oscillatory Activity in Basal Ganglia and Motor Cortex in an Awake Behaving Rodent Model of Parkinson's Disease.

Authors:  Claire Delaville; Ana V Cruz; Alex J McCoy; Elena Brazhnik; Irene Avila; Nikolay Novikov; Judith R Walters
Journal:  Basal Ganglia       Date:  2014-04-01

4.  Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.

Authors:  Javier Iglesias-González; Sofía Sánchez-Iglesias; Estefanía Méndez-Álvarez; Sarah Rose; Atsuko Hikima; Peter Jenner; Ramón Soto-Otero
Journal:  Neurochem Res       Date:  2012-07-22       Impact factor: 3.996

5.  Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat.

Authors:  Michelle Healy-Stoffel; S Omar Ahmad; John A Stanford; Beth Levant
Journal:  Brain Res       Date:  2014-06-09       Impact factor: 3.252

Review 6.  Implications of cellular models of dopamine neurons for disease.

Authors:  Carmen C Canavier; Rebekah C Evans; Andrew M Oster; Eleftheria K Pissadaki; Guillaume Drion; Alexey S Kuznetsov; Boris S Gutkin
Journal:  J Neurophysiol       Date:  2016-08-31       Impact factor: 2.714

7.  Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.

Authors:  W Michael Caudle; Sheng Pan; Min Shi; Thomas Quinn; Jake Hoekstra; Richard P Beyer; Thomas J Montine; Jing Zhang
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

8.  Selective neuronal vulnerability to oxidative stress in the brain.

Authors:  Xinkun Wang; Elias K Michaelis
Journal:  Front Aging Neurosci       Date:  2010-03-30       Impact factor: 5.750

9.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

Review 10.  Functional diversity of ventral midbrain dopamine and GABAergic neurons.

Authors:  Tatiana M Korotkova; Alexei A Ponomarenko; Ritchie E Brown; Helmut L Haas
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.